We are live on ! Find out more
CAM

Claret Asset Management Portfolio holdings

AUM $928M
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
AUM
$862M
AUM Growth
+$22.3M
Cap. Flow
-$22M
Cap. Flow %
-2.56%
Top 10 Hldgs %
40.55%
Holding
418
New
11
Increased
53
Reduced
298
Closed
35

Sector Composition

Rank Sector Weight
1 Technology 22.22%
2 Financials 18.67%
3 Healthcare 16.17%
4 Communication Services 12.61%
5 Consumer Discretionary 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAT icon
126
Waters Corp
WAT
$39.2B
$399K 0.05%
1,049
-2
-0.2% -$736
TRP icon
127
TC Energy
TRP
$66.6B
$396K 0.05%
7,183
-158
-2% -$8.43K
VT icon
128
Vanguard Total World Stock ETF
VT
$79.1B
$396K 0.05%
2,810
-45
-2% -$6.29K
UTHR icon
129
United Therapeutics
UTHR
$22.6B
$393K 0.05%
806
-2
-0.2% -$931
SU icon
130
Suncor Energy
SU
$72.4B
$387K 0.04%
8,720
-384
-4% -$16.2K
GTLS
131
DELISTED
Chart Industries
GTLS
$383K 0.04%
1,855
EXPE icon
132
Expedia Group
EXPE
$36.8B
$380K 0.04%
1,340
-3
-0.2% -$741
CAT icon
133
Caterpillar
CAT
$395B
$379K 0.04%
661
-4
-0.6% -$2.22K
GE icon
134
GE Aerospace
GE
$389B
$378K 0.04%
1,229
-6
-0.5% -$1.81K
PLTR icon
135
Palantir
PLTR
$375B
$378K 0.04%
2,126
HII icon
136
Huntington Ingalls Industries
HII
$12.7B
$365K 0.04%
1,074
-2
-0.2% -$621
MKSI icon
137
MKS Inc
MKSI
$19.7B
$365K 0.04%
2,282
-5
-0.2% -$742
ONTO icon
138
Onto Innovation
ONTO
$13.4B
$365K 0.04%
2,314
-5
-0.2% -$710
JAZZ icon
139
Jazz Pharmaceuticals
JAZZ
$16.7B
$364K 0.04%
2,140
-5
-0.2% -$767
ELAN icon
140
Elanco Animal Health
ELAN
$12.1B
$362K 0.04%
16,014
-38
-0.2% -$827
MCD icon
141
McDonald's
MCD
$196B
$356K 0.04%
1,164
+6
+0.5% +$1.84K
TMO icon
142
Thermo Fisher Scientific
TMO
$214B
$352K 0.04%
608
+29
+5% +$16.4K
FICO icon
143
Fair Isaac
FICO
$22.3B
$346K 0.04%
205
FNV icon
144
Franco-Nevada
FNV
$44.6B
$346K 0.04%
1,669
+55
+3% +$11.2K
LLY icon
145
Eli Lilly
LLY
$1.06T
$343K 0.04%
319
-121
-28% -$116K
GMED icon
146
Globus Medical
GMED
$11B
$341K 0.04%
3,906
-9
-0.2% -$683
REGN icon
147
Regeneron Pharmaceuticals
REGN
$79.5B
$339K 0.04%
439
-1
-0.2% -$679
LSCC icon
148
Lattice Semiconductor
LSCC
$18.3B
$336K 0.04%
4,560
-10
-0.2% -$712
TPR icon
149
Tapestry
TPR
$32.7B
$335K 0.04%
2,626
-6
-0.2% -$686
VTRS icon
150
Viatris
VTRS
$19B
$332K 0.04%
26,706
-59
-0.2% -$637

Similar funds

Claret Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Claret Asset Management held 418 positions worth $862M, up 2.7% from $839M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Claret Asset Management's Q4 2025 filing shows 11 new, 53 increased, 298 reduced and 35 closed positions. Its largest new stake was SunocoCorp LLC: 200,081 shares worth $9.86M. The largest sale was Indivior Pharmaceuticals, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Claret Asset Management's largest Q4 2025 buy was SunocoCorp LLC: 200,081 shares worth $9.86M.
  • Claret Asset Management added most to Canadian National Railway in Q4 2025, an estimated $4.08M increase.
  • Claret Asset Management's biggest Q4 2025 reduction was Quipt Home Medical, cutting an estimated $1.94M.
  • Claret Asset Management fully exited Indivior Pharmaceuticals in Q4 2025, selling an estimated $18.9M.
  • Claret Asset Management's ten largest holdings make up 41% of its $862M portfolio in Q4 2025.
  • Claret Asset Management opened 11 new positions and closed 35 in Q4 2025.
  • Claret Asset Management's portfolio value rose 2.7% quarter-over-quarter to $862M.

Based on Claret Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.